Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kwang Hyub Han

Showing results (271-280 of 527) with videos related to

Pageof 53
Sort By:
Liver International : Official Journal of the International Association for the Study of the Liver|October 4, 2018
Fibrosis-matched outcomes between chronic hepatitis B patients with drug-induced virological response and inactive carriersHye Soo Kim, Oidov Baatarkhuu, Hye Won Lee, et al.
Cardiovascular and Interventional Radiology|June 4, 2016
Cryoablation of Hepatocellular Carcinoma with High-Risk for Percutaneous Ablation: Safety and EfficacyGyoung Min Kim, Jong Yun Won, Man Deuk Kim, et al.
The Korean Journal of Hepatology|July 8, 2010
[Deficiencies in proteins C and S in a patient with idiopathic portal hypertension accompanied by portal vein thrombosis]Sena Hwang, Do Young Kim, Minju Kim, et al.
British Journal of Cancer|June 29, 2019
Urine protein:creatinine ratio vs 24-hour urine protein for proteinuria management: analysis from the phase 3 REFLECT study of lenvatinib vs sorafenib in hepatocellular carcinomaThomas R Jeffry Evans, Masatoshi Kudo, Richard S Finn, et al.
Clinical and Molecular Hepatology|June 1, 2019
Risk assessment of hepatocellular carcinoma development for indeterminate hepatic nodules in patients with chronic hepatitis BHaneulsaem Shin, Yeon Woo Jung, Beom Kyung Kim, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|May 6, 2009
Variability in liver stiffness values from different intercostal spacesSeung Up Kim, Ja Kyung Kim, Jun Yong Park, et al.
Journal of Viral Hepatitis|June 20, 2020
High body mass index hinders fibrosis improvement in patients receiving long-term tenofovir therapy in hepatitis B virus-related cirrhosisYoung Eun Chon, Kyu Sik Jung, Yeonjung Ha, et al.
Hepatology International|February 23, 2017
Subcirrhotic liver stiffness by FibroScan correlates with lower risk of hepatocellular carcinoma in patients with HBV-related cirrhosisMi Young Jeon, Hye Won Lee, Seung Up Kim, et al.
British Journal of Cancer|August 1, 2019
Correction: Urine protein:creatinine ratio vs 24-hour urine protein for proteinuria management: analysis from the phase 3 REFLECT study of lenvatinib vs sorafenib in hepatocellular carcinomaThomas R Jeffry Evans, Masatoshi Kudo, Richard S Finn, et al.
Gastroenterology|February 4, 2014
Hepatitis C virus attenuates interferon-induced major histocompatibility complex class I expression and decreases CD8+ T cell effector functionsWonseok Kang, Pil Soo Sung, Su-Hyung Park, et al.
Pageof 53

Showing results (271-280 of 527) with videos related to

Sort By:
Pageof 53
Liver International : Official Journal of the International Association for the Study of the Liver|October 4, 2018
Fibrosis-matched outcomes between chronic hepatitis B patients with drug-induced virological response and inactive carriersHye Soo Kim, Oidov Baatarkhuu, Hye Won Lee, et al.
Cardiovascular and Interventional Radiology|June 4, 2016
Cryoablation of Hepatocellular Carcinoma with High-Risk for Percutaneous Ablation: Safety and EfficacyGyoung Min Kim, Jong Yun Won, Man Deuk Kim, et al.
The Korean Journal of Hepatology|July 8, 2010
[Deficiencies in proteins C and S in a patient with idiopathic portal hypertension accompanied by portal vein thrombosis]Sena Hwang, Do Young Kim, Minju Kim, et al.
British Journal of Cancer|June 29, 2019
Urine protein:creatinine ratio vs 24-hour urine protein for proteinuria management: analysis from the phase 3 REFLECT study of lenvatinib vs sorafenib in hepatocellular carcinomaThomas R Jeffry Evans, Masatoshi Kudo, Richard S Finn, et al.
Clinical and Molecular Hepatology|June 1, 2019
Risk assessment of hepatocellular carcinoma development for indeterminate hepatic nodules in patients with chronic hepatitis BHaneulsaem Shin, Yeon Woo Jung, Beom Kyung Kim, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|May 6, 2009
Variability in liver stiffness values from different intercostal spacesSeung Up Kim, Ja Kyung Kim, Jun Yong Park, et al.
Journal of Viral Hepatitis|June 20, 2020
High body mass index hinders fibrosis improvement in patients receiving long-term tenofovir therapy in hepatitis B virus-related cirrhosisYoung Eun Chon, Kyu Sik Jung, Yeonjung Ha, et al.
Hepatology International|February 23, 2017
Subcirrhotic liver stiffness by FibroScan correlates with lower risk of hepatocellular carcinoma in patients with HBV-related cirrhosisMi Young Jeon, Hye Won Lee, Seung Up Kim, et al.
British Journal of Cancer|August 1, 2019
Correction: Urine protein:creatinine ratio vs 24-hour urine protein for proteinuria management: analysis from the phase 3 REFLECT study of lenvatinib vs sorafenib in hepatocellular carcinomaThomas R Jeffry Evans, Masatoshi Kudo, Richard S Finn, et al.
Gastroenterology|February 4, 2014
Hepatitis C virus attenuates interferon-induced major histocompatibility complex class I expression and decreases CD8+ T cell effector functionsWonseok Kang, Pil Soo Sung, Su-Hyung Park, et al.
Pageof 53